Literature DB >> 18654836

Adverse-drug-reaction related admissions to a hospital in Scotland.

Yvonne Hopf1, Margaret Watson, David Williams.   

Abstract

AIMS: To apply established methods to identify ADR-related admissions and to determine the proportion which was preventable and which were caused by non-prescription medicines (NPMs).
METHODS: This prospective, observational study screened all acute hospital admissions (n = 1,101) by ward pharmacists over a 2-week period. Suspected ADR-related admissions were reported to the researcher and established criteria were used to evaluate probability, causality and preventability of the ADR-related admissions.
RESULTS: Of the 1,101 emergency admissions which occurred during the study period, 30 were categorised as ADR-related, equating to a prevalence of 2.7% (95% CI, 1.8-3.7%). Three (9.7%) of the 30 admissions were associated with NPMs. The ADR was the dominant reason for admission in 56.7% (n = 17/30) and only 13.3% (n = 4/30) of all reported admissions were assessed as unavoidable.
CONCLUSION: The proportion of ADR-related admissions was lower than in previous studies in the UK. A substantial proportion of ADRs was associated with NPMs, highlighting the need for greater awareness amongst patients, prescribers and other health care professionals regarding possible serious adverse effects caused by these medicines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18654836     DOI: 10.1007/s11096-008-9240-5

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  17 in total

1.  Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study.

Authors:  C F Green; D R Mottram; P H Rowe; M Pirmohamed
Journal:  J Clin Pharm Ther       Date:  2000-10       Impact factor: 2.512

2.  Underreporting of adverse drug reactions: attitudes of Irish doctors.

Authors:  D Williams; J Feely
Journal:  Ir J Med Sci       Date:  1999 Oct-Dec       Impact factor: 1.568

3.  Adverse drug reaction monitoring--cost and benefit considerations. Part I: frequency of adverse drug reactions causing hospital admissions.

Authors:  N Muehlberger; S Schneeweiss; J Hasford
Journal:  Pharmacoepidemiol Drug Saf       Date:  1997-10       Impact factor: 2.890

Review 4.  National differences in publishing papers on adverse drug reactions.

Authors:  R E Ferner; J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

5.  Hospital admissions for 'drug-induced' disorders in England: a study using the Hospital Episodes Statistics (HES) database.

Authors:  Patrick Waller; Mary Shaw; Davidson Ho; Saad Shakir; Shah Ebrahim
Journal:  Br J Clin Pharmacol       Date:  2005-02       Impact factor: 4.335

6.  Adverse drug reactions result in 250,000 UK admissions a year.

Authors:  Lisa Hitchen
Journal:  BMJ       Date:  2006-05-13

Review 7.  Adverse drug reactions.

Authors:  M Pirmohamed; A M Breckenridge; N R Kitteringham; B K Park
Journal:  BMJ       Date:  1998-04-25

8.  Garlic and the strabismus surgeon.

Authors:  Susan M Carden; William V Good; Patricia A Carden; Robert M Good
Journal:  Clin Exp Ophthalmol       Date:  2002-08       Impact factor: 4.207

9.  Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study.

Authors:  R L Howard; A J Avery; P D Howard; M Partridge
Journal:  Qual Saf Health Care       Date:  2003-08

Review 10.  Important drug-drug interactions in the elderly.

Authors:  R M Seymour; P A Routledge
Journal:  Drugs Aging       Date:  1998-06       Impact factor: 4.271

View more
  22 in total

Review 1.  A systematic review of hospitalization resulting from medicine-related problems in adult patients.

Authors:  Abdullah Al Hamid; Maisoon Ghaleb; Hisham Aljadhey; Zoe Aslanpour
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

2.  The relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysis.

Authors:  Anne J Leendertse; Djurre Visser; Antoine C G Egberts; Patricia M L A van den Bemt
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

Review 3.  Hospitalizations due to preventable adverse reactions-a systematic review.

Authors:  Nidhi S Patel; Tejas K Patel; Parvati B Patel; Viren N Naik; C B Tripathi
Journal:  Eur J Clin Pharmacol       Date:  2016-12-02       Impact factor: 2.953

4.  Cost-effectiveness of outpatient parenteral antibiotic therapy: a simulation modelling approach.

Authors:  A Vargas-Palacios; D M Meads; M Twiddy; C Czoski Murray; C Hulme; E D Mitchell; A Gregson; P Stanley; J Minton
Journal:  J Antimicrob Chemother       Date:  2017-08-01       Impact factor: 5.790

Review 5.  Identifying high-risk medication: a systematic literature review.

Authors:  Eva A Saedder; Birgitte Brock; Lars Peter Nielsen; Dorthe K Bonnerup; Marianne Lisby
Journal:  Eur J Clin Pharmacol       Date:  2014-03-27       Impact factor: 2.953

6.  Adverse drug reactions as a cause of admission to a Dublin-based university teaching hospital.

Authors:  D Walsh; A Lavan; A-M Cushen; D Williams
Journal:  Ir J Med Sci       Date:  2014-06-05       Impact factor: 1.568

Review 7.  Methods for assessing the preventability of adverse drug events: a systematic review.

Authors:  Katja Marja Hakkarainen; Karolina Andersson Sundell; Max Petzold; Staffan Hägg
Journal:  Drug Saf       Date:  2012-02-01       Impact factor: 5.606

8.  Mortality among patients due to adverse drug reactions that lead to hospitalization: a meta-analysis.

Authors:  Tejas K Patel; Parvati B Patel
Journal:  Eur J Clin Pharmacol       Date:  2018-03-19       Impact factor: 2.953

Review 9.  Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors.

Authors:  Mulugeta Tarekegn Angamo; Leanne Chalmers; Colin M Curtain; Luke R E Bereznicki
Journal:  Drug Saf       Date:  2016-09       Impact factor: 5.606

10.  Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission.

Authors:  Consuelo Pedrós; Beatriz Quintana; Mireia Rebolledo; Núria Porta; Antoni Vallano; Josep Maria Arnau
Journal:  Eur J Clin Pharmacol       Date:  2013-12-21       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.